Skip to main content
. 2011 May 1;2:232–261. doi: 10.7150/jca.2.232

Table 2.

Expression rates of steroid receptors in DCIS

Biomarker First author and reference Year No. of samples Expression rate, % Definition of positivity
Estrogen receptor (ER)
Albonico 7 1998 62 28.8-92.6 Nuclear staining in at least 10% of tumor cells. 28.8 (comedo DCIS) 78.9 (noncomedo DCIS) 92.6 (cribriform DCIS)
Claus 9 2001 219 60 No cut-off value was mentioned in the paper.
Bijker 10 2001 116 62.9 Any ER expression.
Ringberg 16 2001 187 60 Nuclear staining in more than 10% of tumor cells.
Wärnberg 36 2001 194 68 Nuclear staining in at least 10% of tumor cells.
Oh 41 2001 49 65.3 Nuclear staining in more than 5% of tumor cells.
Lebrecht 11 2002 120 71.7 Moderate or strong nuclear staining in tumor cells.
DiGiovanna 17 2002 219 60 Nuclear staining in more than 10% of tumor cells.
Provenzano 22 2003 95 49 Nuclear staining in at least 10% of tumor cells.
Lebeau 12 2003 45 55 Nuclear staining in at least 10% of tumor cells.
Roka 23 2004 190 57.9 Nuclear staining in at least 10% of tumor cells.
Boland 19 2004 187 59.7 Nuclear staining in at least 5% of tumor cells.
Barnes 35 2005 129 66.4 Nuclear staining in at least 5% of tumor cells.
Perrone 20 2005 49 75.5 Nuclear staining in more than 10% of tumor cells.
Collins 13 2005 148 77 Nuclear staining in at least 10% of tumor cells.
Gauthier 62 2005 30 78.9 No cut-off value was mentioned in the paper.
Bryan 65 2006 66 56 Nuclear staining in at least 10% of tumor cells. All cases were high-nuclear-grade DCIS.
Kepple 59 2006 94 74 No cut-off value was mentioned in the paper
Wilson 37 2006 129 65.1 Nuclear staining in at least 5% of tumor cells.
Barnes 54 2006 161 63.6 Nuclear staining in at least 5% of tumor cells.
Millar 31 2007 60 58.3 Nuclear staining in more than 10% of tumor cells.
Livasy 66 2007 245 70 Allred score above 2.
Meijnen 14 2008 163 68 Any ER expression.
Hanley 8 2008 90 30 (high-grade DCIS);96 (non-high-grade DCIS) Nuclear staining in at least 10% of tumor cells.
Tamimi 67 2008 272 74 Nuclear staining in more than 10% of tumor cells.
Okumura 52 2008 52 73.1 Nuclear staining in more than 10% of tumor cells.
Kulkarni 21 2008 69 77.8 Nuclear staining in at least 10% of tumor cells.
Roses 68 2009 84 76.2 Allred score less than or equal to 3.
Suzuki 69 2009 58 60 Nuclear staining in at least 1% of tumor cells.
Altintas 15 2009 159 72 Nuclear staining in at least10% of tumor cells.
Yu K 70 2010 271 67.3 Results of immunohistochemical assays were evaluated using a proportion score and an intensity score. Tumors that scored over 1 were scored as positive.
Kuerer 18 2010 69 81 No cut-off value was mentioned in the paper.
Kerlikowske 24 2010 329 77.9 Nuclear staining in at least 10% of tumor cells.
Behling 71 2010 65 78 No cut-off value was mentioned in the paper.
Witkiewicz 61 2010 97 96.6 Status obtained from the pathology reports.
Holmes 58 2011 141 80.9 Nuclear staining was assessed in tumors and assigned a score. Tumors with staining in 0-9% of cells were given a score of 3, tumors with staining in 10-79% of cells were given a score of 2, and tumors with staining in 80% or more of cells were given a score of 1. Scores 1 and 2 were considered to be positive.
Progesterone receptor (PR)
Albonico 7 1998 62 28.2-89.1 Nuclear staining in at least 10% of tumor cells. 28.2 (comedo DCIS) 75.3 (noncomedo DCIS) 89.1 (cribriform DCIS)
Claus 9 2001 219 62 No cut-off value was mentioned in the paper.
Bijker 10 2001 116 47.1 Any PR expression.
Ringberg 16 2001 187 43 Nuclear staining in more than 10% of tumor cells.
Wärnberg 36 2001 194 43 Nuclear staining in at least 10% of tumor cells.
DiGiovanna 17 2002 219 62 Nuclear staining in more than 10% of tumor cells.
Provenzano 22 2003 95 48 Nuclear staining in at least 10% of tumor cells.
Lebeau 12 2003 45 50 Nuclear staining in at least 10% of tumor cells.
Roka 23 2004 190 41 Nuclear staining in at least 10% of tumor cells.
Perrone 20 2005 49 65.3 Nuclear staining in more than 10% of tumor cells.
Gauthier 62 2005 30 70.8 No cut-off value was mentioned in the paper.
Bryan 65 2006 66 40 Nuclear staining in at least 10% of tumor cells. All cases were high-nuclear-grade DCIS.
Kepple 59 2006 94 56 No cut-off value was mentioned in the paper.
Millar 31 2007 60 56.1 Nuclear staining in more than 10% of tumor cells.
Meijnen 14 2008 163 46 Any PR expression.
Hanley 8 2008 90 23 (high-grade DCIS);81 (non-high-grade DCIS) Nuclear staining in at least 10% of tumor cells.
Tamimi 67 2008 272 59.9 Nuclear staining in more than 10% of tumor cells.
Okumura 52 2008 52 71.2 Nuclear staining in more than 10% of tumor cells.
Kulkarni 21 2008 69 75.9 Nuclear staining in more than 10% of tumor cells.
Roses 68 2009 84 68.3 Allred score less than or equal to 3.
Suzuki 69 2009 58 55 Nuclear staining in at least 1% of tumor cells.
Altintas 15 2009 159 65 Nuclear staining in at least 10% of tumor cells.
Yu K 70 2010 271 52.7 Results of immunohistochemical assays were evaluated using a proportion score and an intensity score. Tumors that scored over 1 were scored as positive.
Bundred 30 2010 90 72 Nuclear staining in more than 5% of tumor cells. All cases were ER-positive DCIS.
Kerlikowske 24 2010 329 74.5 Nuclear staining in at least 10% of tumor cells.
Behling 71 2010 65 71.2 No cut-off value was mentioned in the paper.
Witkiewicz 61 2010 97 83.3 Status obtained from pathology reports.
Holmes 58 2011 141 70.9 Nuclear staining was assessed in tumors and assigned a score. Tumors with staining in 0-9% of cells were given a score of 3, tumors with staining in 10-79% of cells were given a score of 2, and tumors with staining in 80% or more of cells were given a score of 1. Scores 1 and 2 were considered to be positive.
Androgen receptor (AR)
Provenzano 22 2003 95 81 Nuclear staining in at least 10% of tumor cells.
Meijnen 14 2008 163 37 Strong nuclear staining in more than 10% of tumor cells.
Hanley 8 2008 90 89 (non-high-grade DCIS);93 (high-grade DCIS) Nuclear staining in at least 10% of tumor cells.
Yu Q. 33 2010 34 79.4 Allred score of 2.